Luke Nolan

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

John Bridgewater, S. Pugh, Tom Maishman et al. · The Lancet Oncology · 2020 · 227 citations · Full text

Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1–Deficient Malignant Pleural Mesothelioma

Peter W. Szlosarek, Jeremy Steele, Luke Nolan et al. · JAMA Oncology · 2016 · 190 citations · Full text

Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND—A Double-Blind, Randomized, Phase II Study

Dean A. Fennell, Paul Baas, Paul Taylor et al. · Journal of Clinical Oncology · 2019 · 123 citations

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

Edurne Arriola, Matthew Wheater, Ian Galea et al. · Journal of Thoracic Oncology · 2016 · 113 citations · Full text

Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer

Max Hardy-Werbin, Pedro Rocha, Oriol Arpí et al. · OncoImmunology · 2019 · 85 citations · Full text